Finasteride and Sexual Dysfunction

The study found that men given finasteride reported on average more dysfunction than did men given a placebo. That small effect diminished over the seven years.

The results allay concerns about a negative side effect associated with finasteride up till now. Physicians usually warn that sexual dysfunction is a possibility when they discuss the drug with patients. Finasteride is an FDA-approved drug for the treatment of benign prostatic hyperplasia, but it is not yet FDA-approved for the prevention or reduction in risk for prostate cancer.

The study’s large sample and long follow-up period allowed researchers to examine whether or not finasteride negatively affected sexual function and, if so, whether this effect was lasting.

The study grew out of the Prostate Cancer Prevention Trial, a large double-blind National Cancer Institute-funded study which found that finasteride, a drug which curbs the proliferation of prostate gland cells, is effective at preventing prostate cancer in men age 55 and older. The 2003 results of that trial, conducted by the Southwest Oncology Group in more than 18,000 men, showed that finasteride could reduce a man’s chances of getting prostate cancer by almost 25 percent.

The authors of the newly published sexual function results wanted to assess how many men in the Prostate Cancer Prevention Trial reported experiencing sexual dysfunction, and whether the problems decreased or increased over time. In earlier studies, some men taking finasteride reported decreased libido, impotence and other signs of diminished sexual function. But these studies were short-term and didn’t try to assess the effects of age and other health factors, as well as individual variation.

The study authors used two surveys, a widely used Sexual Problems Scale and another questionnaire which they created, the Sexual Activity Scale. They also gathered other data to take into account other health factors that affect sexual function, such as age, medical conditions and smoking status. They surveyed the subjects three times in the first year and then annually for seven years.

The study suggests that finasteride will cause little or no sexual dysfunction for most men who decide to take it, conclude the authors.

New effect of viagra

Recently, researchers studied effects of viagra and have found out the early unknown and not studied viagra effect.

It has appeared that viagra helps to adapt and more quickly to come to the normal physical form at change of time zones
In other words, viagra can help at distant flights

Researches were on animals and they have shown that viagra helps them to restore twice more quickly the physical condition, at change of time cycles. Even at small doses which does not cause an erection, viagra has shown the efficiency.
But viagra shows such effect only if there is a change of time in western a direction

But before it will be possible to use viagra in new quality it is necessary to carry out additional researches and to make some tests with people
Meanwhile the manufacturer of Viagra, concern Pfizer, declares that viagra can be used only as Erectile Dysfunction Medication for man

Finasteride approved

The FDA has approved Finasteride Tablets, USP 5 mg, manufactured Actavis Group (OMX: ACT), international generic pharmaceutical companies specializing in the development, manufacture and sale of generic pharmaceuticals.
Finasteride 5mg tablets are the generic equivalent of Proscar tablets which are indicated for the treatment of
benign prostatic hyperplasia in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of the need  prostate surgery.

LEVAQUIN is more effective

The company that markets LEVAQUIN in the U.S.,
presented the data during a scientific session that a short course of five
LEVAQUIN (levofloxacin) 750 mg tablets
administered once-daily for five days is as effective as standard therapy
of ciprofloxacin (400/500 mg) for 10 days for the treatment of complicated
urinary tract infections and acute pyelonephritis.

LEVAQUIN is available in 250
mg, 500 mg and 750 mg doses in both oral and I.V. formulations.
Since its introduction in 1996, LEVAQUIN has gained widespread use
in the treatment for a variety of bacterial infections caused by
susceptible pathogens, such us chronic bacterial prostatitis, urinary tract infections
and acute pyelonephritis (mild to moderate) acute bacterial sinusitis, nosocomial pneumonia, acute
bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated and uncomplicated skin and skin
structure infections .

Lybrel new birth control pill

The U.S. Food and Drug Administration is expect to announce approval for Lybrel, non-cyclic combination oral contraceptive.
Lybrel would be the fourth after Yaz, Loestrin 24, and Seasonique new version of Seasonale new oral contraceptive that doesn’t follow the standard schedule of 21 daily active pills, followed by seven sugar pills.
Lybrel contains the lowest dose of two hormones widely used in birth-control pills, ethinyl estradiol and levonorgestrel.
Low hormone doses might cause too much breakthrough bleeding.
In testing of Lybrel, 59 percent of women ended up with no bleeding after six months, but 18 percent of women dropped out of studies because of spotting and breakthrough bleeding.